Introduction:Basic information about CAS 179474-81-8|prucalopride, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | prucalopride |
|---|
| CAS Number | 179474-81-8 | Molecular Weight | 367.870 |
|---|
| Density | 1.3±0.1 g/cm3 | Boiling Point | 481.4±45.0 °C at 760 mmHg |
|---|
| Molecular Formula | C18H26ClN3O3 | Melting Point | 90.7° |
|---|
| MSDS | ChineseUSA | Flash Point | 244.9±28.7 °C |
|---|
| Symbol | GHS07, GHS09 | Signal Word | Warning |
|---|
Names
| Name | Prucalopride |
|---|
| Synonym | More Synonyms |
|---|
prucalopride BiologicalActivity
| Description | Prucalopride (R093877) is a drug acting as a selective, high affinity 5-HT4 receptor agonist(pKi=8.6/8.1 for 5-HT4a/4b); >150-fold higher affinity for 5-HT4 receptors than for other receptors.IC50 value: 8.6/8.1 for 5-HT4a/4b(pKi)Target: 5-HT4 receptorPrucalopride is a novel enterokinetic compound and is the first representative of the benzofuran class. Receptor binding data have demonstrated prucalopride's high affinity to both investigated 5-HT(4) receptor isoforms, with mean pK(i) estimates of 8.60 and 8.10 for the human 5-HT(4a) and 5-HT(4b) receptor, respectively. From the 50 other binding assays investigated in this study only the human D(4) receptor (pK(i) 5.63), the mouse 5-HT(3) receptor (pK(i) 5.41) and the human sigma(1) (pK(i) 5.43) have shown measurable affinity, resulting in at least 290-fold selectivity for the 5-HT(4) receptor [1]. |
|---|
| Related Catalog | Signaling Pathways >>GPCR/G Protein >>5-HT ReceptorSignaling Pathways >>Neuronal Signaling >>5-HT ReceptorResearch Areas >>Neurological Disease |
|---|
| References | [1]. Briejer MR, et al. The in vitro pharmacological profile of prucalopride, a novel enterokinetic compound. Eur J Pharmacol. 2001 Jun 29;423(1):71-83. [2]. Emmanuel AV, et al. Randomised clinical trial: the efficacy of prucalopride in patients with chronic intestinal pseudo-obstruction--a double-blind, placebo-controlled, cross-over, multiple n = 1 study. Aliment Pharmacol Ther. 2012 Jan;35(1):48-55. [3]. Bouras EP, et al. Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans. Gut. 1999 May;44(5):682-6. |
|---|
Chemical & Physical Properties
| Density | 1.3±0.1 g/cm3 |
|---|
| Boiling Point | 481.4±45.0 °C at 760 mmHg |
|---|
| Melting Point | 90.7° |
|---|
| Molecular Formula | C18H26ClN3O3 |
|---|
| Molecular Weight | 367.870 |
|---|
| Flash Point | 244.9±28.7 °C |
|---|
| Exact Mass | 367.166260 |
|---|
| PSA | 76.82000 |
|---|
| LogP | 1.44 |
|---|
| Vapour Pressure | 0.0±1.2 mmHg at 25°C |
|---|
| Index of Refraction | 1.599 |
|---|
| InChIKey | ZPMNHBXQOOVQJL-UHFFFAOYSA-N |
|---|
| SMILES | COCCCN1CCC(NC(=O)c2cc(Cl)c(N)c3c2OCC3)CC1 |
|---|
Safety Information
| Symbol | GHS07, GHS09 |
|---|
| Signal Word | Warning |
|---|
| Hazard Statements | H315-H319-H335-H400 |
|---|
| Precautionary Statements | P305 + P351 + P338 |
|---|
| Hazard Codes | Xi |
|---|
| RIDADR | UN 3077 9 / PGIII |
|---|
Synonyms
| 4-Amino-5-chloro-N-[1-(3-methoxypropyl)-4-piperidinyl]-2,3-dihydro-1-benzofuran-7-carboxamide |
| prucalopride |
| 4-Amino-5-chloro-2,3-dihydro-N-[1-(3-methoxypropyl)-4-piperidinyl]-7-benzofurancarboxamide |
| Resolor |
| 7-Benzofurancarboxamide, 4-amino-5-chloro-2,3-dihydro-N-[1-(3-methoxypropyl)-4-piperidinyl]- |
| 4-Amino-5-chloro-N-[1-(3-methoxypropyl)piperidin-4-yl]-2,3-dihydro-1-benzofuran-7-carboxamide |
| Unii-0A09iuw5tp |